CVE-2026-47133ClearanceKit intercepts file-system access events on macOS and enforces per-process access policies.
Updated under an hour ago ()
Does this affect you?
It lists no affected products yet. Add what you run and Signals checks it as products are added.
No exploitation reported and no EPSS estimate yet.
ClearanceKit intercepts file-system access events on macOS and enforces per-process access policies. Prior to version 5.0.10, each table in the on-disk SQLite policy store (`/Library/Application Support/clearancekit/store.db`) is verified using an ECDSA signature stored in the `data_signatures` table. The signed payload contains only the canonical row content, with no version counter or freshness binding. An attacker who can write `store.db` and the matching `data_signatures` row — feasible during the opfilter-update window when the Endpoint Security filter is offline, or via offline-boot / decrypted-backup scenarios — can substitute a previously-captured legitimately-signed snapshot. opfilter accepts the older snapshot as fully valid on next boot because the existing signatures still verify. Version 5.0.10 patches the issue.
- CVSS
- 6.9 MEDIUM (v4.0, NVD)CVSS:4.0/AV:L/AC:L/AT:P/PR:H/UI:N/VC:N/VI:H/VA:N/SC:H/SI:H/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
- Weakness (CWE)
- CWE-294
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Deferred
- Record last updated
- Jul 23, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
No affected products are listed yet.
References
- https://github.com/craigjbass/clearancekit/security/advisories/GHSA-9hx3-5wp9-2qqg
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.